Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Sanofi updates financials to exclude Opella division, focusing more on biopharma.

flag Sanofi has updated its financial statements to exclude its Opella consumer healthcare division, as the company plans to transfer a 50% stake to CD&R. flag The revised data, reviewed by auditors, includes sales and business net income, and will be listed as discontinued operations. flag Sanofi is aiming to focus more on biopharma. flag The company's Q4 2024 results, reflecting the new scope, will be released on January 30, 2025.

5 Articles

Further Reading